PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9705435::ACT054509

Bradykinin

Evidence text

Paper-level observation

Figure 5a: Bradykinin EC50 for PGE2 release in nanomolar range
unknownConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Other
Measure
EC50
Comparator
=
Raw observation
nanomolar range
Normalized measurement
=0 nM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
3T3
Assay method
Not reported by source
Sequence
RPPGFSPFR
Standardization
ready simple

Source publication

Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates.

Nature Communications · 2022

DOI 10.1038/s41467-022-34712-9 PMC9705435
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003998PEPDIA-INT-058212

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.